Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases.
Int J Clin Oncol. 2014.
PMID: 23877652
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1913 | 1 |
| 1925 | 1 |
| 1946 | 1 |
| 1948 | 1 |
| 1950 | 1 |
| 1951 | 5 |
| 1952 | 2 |
| 1954 | 1 |
| 1956 | 3 |
| 1957 | 5 |
| 1958 | 1 |
| 1959 | 6 |
| 1960 | 5 |
| 1961 | 6 |
| 1962 | 4 |
| 1963 | 3 |
| 1964 | 4 |
| 1965 | 6 |
| 1966 | 4 |
| 1967 | 3 |
| 1968 | 4 |
| 1969 | 3 |
| 1970 | 1 |
| 1971 | 6 |
| 1972 | 5 |
| 1973 | 2 |
| 1974 | 4 |
| 1975 | 2 |
| 1976 | 2 |
| 1977 | 5 |
| 1978 | 4 |
| 1979 | 2 |
| 1980 | 4 |
| 1981 | 3 |
| 1982 | 5 |
| 1983 | 2 |
| 1984 | 7 |
| 1985 | 8 |
| 1986 | 10 |
| 1987 | 12 |
| 1988 | 10 |
| 1989 | 8 |
| 1990 | 10 |
| 1991 | 9 |
| 1992 | 6 |
| 1993 | 11 |
| 1994 | 11 |
| 1995 | 13 |
| 1996 | 10 |
| 1997 | 16 |
| 1998 | 12 |
| 1999 | 7 |
| 2000 | 16 |
| 2001 | 24 |
| 2002 | 17 |
| 2003 | 13 |
| 2004 | 17 |
| 2005 | 22 |
| 2006 | 14 |
| 2007 | 20 |
| 2008 | 16 |
| 2009 | 32 |
| 2010 | 25 |
| 2011 | 23 |
| 2012 | 35 |
| 2013 | 30 |
| 2014 | 35 |
| 2015 | 17 |
| 2016 | 22 |
| 2017 | 30 |
| 2018 | 32 |
| 2019 | 17 |
| 2020 | 18 |
| 2021 | 18 |
| 2022 | 16 |
| 2023 | 19 |
| 2024 | 5 |
Search Results
746 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Strontium Chloride Sr 89.
2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–.
2018 Dec 3. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–.
PMID: 29999761
Free Books & Documents.
Review.
IInformation in this record refers to the use of strontium 89 as a therapeutic agent. No information is available on the therapeutic use of strontium 89 during breastfeeding. It has been estimated that about 9% of the strontium in the maternal b …
IInformation in this record refers to the use of strontium 89 as a therapeutic agent. No information is available on the thera …
Strontium chloride Sr 89 for treating pain from metastatic bone disease.
Am J Health Syst Pharm. 1995 Oct 15;52(20):2189-95. doi: 10.1093/ajhp/52.20.2189.
Am J Health Syst Pharm. 1995.
PMID: 8564588
Review.
The role of strontium chloride Sr 89 in the palliative treatment of pain associated with metastatic bone disease is reviewed. ...An analogue of calcium, strontium chloride Sr 89 is rapidly cleared from the blood after i.v. i …
The role of strontium chloride Sr 89 in the palliative treatment of pain associated with metastatic bone disease …
Strontium-89 (Sr-89) chloride in the treatment of various cancer patients with multiple bone metastases.
Int J Clin Oncol. 2014 Aug;19(4):739-43. doi: 10.1007/s10147-013-0597-7. Epub 2013 Jul 24.
Int J Clin Oncol. 2014.
PMID: 23877652
BACKGROUND: Although the use of Sr-89 chloride in the treatment of patients with prostate and breast cancer has been widely reported, little information is available about its use for other malignancies. Here, we retrospectively analyzed the clinical profile of S …
BACKGROUND: Although the use of Sr-89 chloride in the treatment of patients with prostate and breast cancer has been widely re …
Strontium-89 chloride delivery for painful bone metastases in patients with a history of prior irradiation.
Ir J Med Sci. 2023 Apr;192(2):569-574. doi: 10.1007/s11845-022-03023-9. Epub 2022 May 10.
Ir J Med Sci. 2023.
PMID: 35538276
METHODS: We retrospectively reviewed patients with Sr-89 injection for painful bone metastasis in a previously irradiated site. ...Sr-89 is an option for patients with a painful bone metastasis in a previously irradiated site....
METHODS: We retrospectively reviewed patients with Sr-89 injection for painful bone metastasis in a previously irradiated site …
Novel approach for strontium preconcentration from seawater and rapid determination of (89,90)Sr in emergency situations.
Talanta. 2022 Dec 1;250:123722. doi: 10.1016/j.talanta.2022.123722. Epub 2022 Jul 6.
Talanta. 2022.
PMID: 35816780
To address this issue, the ability of zeolite 4A to concentrate the Sr from the seawater matrix was employed. With the proposed method, two important goals were achieved: (i) simple preconcentration of Sr that can be conducted directly at the sampling site, enabling …
To address this issue, the ability of zeolite 4A to concentrate the Sr from the seawater matrix was employed. With the proposed metho …
Comparison of the efficacy of strontium-89 chloride in treating bone metastasis of lung, breast, and prostate cancers.
J Cancer Res Ther. 2018;14(Supplement):S36-S40. doi: 10.4103/0973-1482.181172.
J Cancer Res Ther. 2018.
PMID: 29578147
Free article.
OBJECTIVE: The aim of this study was to comparatively evaluate the efficacy of strontium-89 chloride ((89) SrCl(2)) in treating bone metastasis-associated pain in patients with lung, breast, or prostate cancer. ...Approximately 67% of patients with lun …
OBJECTIVE: The aim of this study was to comparatively evaluate the efficacy of strontium-89 chloride ((89) SrCl( …
Radiostrontium transport in plants and phytoremediation.
Environ Sci Pollut Res Int. 2018 Oct;25(30):29996-30008. doi: 10.1007/s11356-018-3088-6. Epub 2018 Sep 5.
Environ Sci Pollut Res Int. 2018.
PMID: 30187403
Review.
Radiostrontium is a common product of nuclear fission and was emitted into the environment in the course of nuclear weapon tests as well as from nuclear reactor accidents. The release of (90)Sr and (89)Sr into the environment can pose health threats due to th …
Radiostrontium is a common product of nuclear fission and was emitted into the environment in the course of nuclear weapon tests as well as …
Rapid and simultaneous determination of Strontium-89 and Strontium-90 in seawater.
J Environ Radioact. 2016 Mar;153:214-221. doi: 10.1016/j.jenvrad.2016.01.003. Epub 2016 Jan 21.
J Environ Radioact. 2016.
PMID: 26803402
The method was validated using spiked seawater samples at various activity ratios of (89)Sr:(90)Sr ranging from 1:10 to 9:1. The mean chemical recovery of Sr was 85 3%. (90)Sr showed variable relative bias which enhanced with increasing ratio of …
The method was validated using spiked seawater samples at various activity ratios of (89)Sr:(90)Sr ranging from 1:10 to …
WITHDRAWN: Radioisotopes for metastatic bone pain.
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD003347. doi: 10.1002/14651858.CD003347.pub3.
Cochrane Database Syst Rev. 2017.
PMID: 28334435
Free PMC article.
Review.
Pain flares were not higher in the radioisotopes group (RR 0.74; 95% CI 0.27 to 2.06). There are scarce data of moderate quality when comparing Strontium-89 ((89)Sr) with Samarium-153 ((153)Sm), Rhenium-186 ((186)Re) and Phosphorus-32 ((32)P). ...AUTHO …
Pain flares were not higher in the radioisotopes group (RR 0.74; 95% CI 0.27 to 2.06). There are scarce data of moderate quality when compar …
Characteristic X-ray imaging for palliative therapy using strontium-89 chloride: understanding the mechanism of nuclear medicine imaging of strontium-89 chloride.
Radiol Phys Technol. 2017 Jun;10(2):227-233. doi: 10.1007/s12194-016-0388-8. Epub 2017 Jan 4.
Radiol Phys Technol. 2017.
PMID: 28054241
Strontium-89 (Sr-89) chloride is a targeted palliative therapy used for painful bone metastasis in which repeated doses can be administered, and its usefulness has been reported in the case of bone metastasis of various primary tumors. ...In this study …
Strontium-89 (Sr-89) chloride is a targeted palliative therapy used for painful bone metastasis in which repeate …
Cite